Bulk Manufacturer of Controlled Substances Application: Curia Missouri Inc., 1434-1435 [2022-00325]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
1434
Federal Register / Vol. 87, No. 7 / Tuesday, January 11, 2022 / Notices
Shenzhen City Yaxin General
Machinery Co., Ltd. Mot. at 1. Order No.
12 (Nov. 6, 2020), unreviewed by Notice
(Nov. 24, 2020); see 85 FR 77239–40
(Dec. 1, 2020). The Commission
terminated the investigation as to the
following respondents based on consent
orders and/or settlement agreements:
Eddie Bauer LLC and PSEB Holdings,
LLC; DHgate; Everich and Tomic
Houseware Co., Ltd. Order No. 13 (Nov.
30, 2020), unreviewed by Notice (Dec.
21, 2020); Order No. 17 (Jan. 27, 2021),
unreviewed by Notice (Feb. 16, 2021);
Order No. 19 (Feb. 22, 2021),
unreviewed by Notice (Mar. 12, 2021).
The Commission also terminated the
investigation with respect to the ’282
trademark. Order No. 16 (Jan. 11, 2021),
unreviewed by Notice (Feb. 8, 2021).
On April 14, 2021, the Commission
found the Defaulting Respondents in
default. Order No. 21 (Mar. 22, 2021),
unreviewed by Notice (Apr. 14, 2021).
The Commission also permitted Hydro
Flask to withdraw the amended
complaint as to the remaining
respondents: HydroFlaskPup, Yiwu
Honglu Daily Necessities Co., Ltd., and
Yiwu Houju E-commerce Firm. Order
No. 22 (Apr. 7, 2021), unreviewed by
Notice (Apr. 22, 2021).
On April 8, 2021, Hydro Flask filed a
motion for summary determination of a
violation of section 337 pursuant to
Commission Rules 210.16(c)(2), 210.18
(19 CFR 210.16(c)(2), 210.18) to support
its request for entry of a GEO with
respect to all asserted patents and
trademarks. On August 9, 2021, OUII
filed a response in support of the
motion.
On September 3, 2021, the presiding
chief administrative law judge (‘‘CALJ’’)
issued an initial determination (‘‘ID’’)
granting in part Hydro Flask’s motion
for summary determination. The ID
finds that Hydro Flask has shown by
reliable, probative, and substantial
evidence that a violation of section 337
has occurred with respect to the ’784,
’365, and ’888 trademarks, and the
D’468, D’012, and D’320 patents, and
that the domestic industry requirement
is satisfied for the infringed trademarks
and patents. The ID finds that a
violation has been established with
respect to ten out of thirteen defaulting
respondents: Cangnan Kaiyisi ECommerce Technology Co., Ltd.;
Yongkang Huiyun Commodity Co., Ltd.;
Wuyi Loncin Bottle Co., Ltd.; Zhejiang
Yongkang Unique Industry & Trade Co.,
Ltd.; Suzhou Prime Gifts Co., Ltd.;
Hangzhou Yuehua Technology Co., Ltd.;
Guangzhou Yawen Technology Co.,
Ltd.; Jinhua City Ruizhi E-Commerce
Co., Ltd.; Wo Ma Te (Tianjin)
International Trade Co., Ltd.; and
VerDate Sep<11>2014
20:31 Jan 10, 2022
Jkt 256001
Shenzhen City Yaxin General
Machinery Co., Ltd. The ID also finds
that no violation has been established as
to respondents Shenzhen Huichengyuan
Technology Co., Ltd.; Sinbada Impex
Co., Ltd.; and Zhejiang Yuchuan
Industry & Trade Co., Ltd.
The ID contains the CALJ’s
recommended determination on remedy
and bonding (‘‘RD’’). The RD
recommends issuance of a GEO with
respect to the asserted patents and
trademarks. The RD does not
recommend issuance of any cease and
desist orders. No petitions for review
were filed.
The Commission determined to
review the subject ID in part. See 86 FR
59424–26 (Oct. 27, 2021). Specifically,
the Commission determined to review
the ID’s finding that Hydro Flask has
satisfied the economic prong of the
domestic industry requirement under
section 337(a)(3)(A). Id.; see ID at 89–92.
On review, the Commission affirmed the
ID’s finding that Hydro Flask has
established a domestic industry under
section 337(a)(3)(A). Id. The
Commission also requested written
submissions on remedy, the public
interest, and bonding. Id.
On November 4, 2021, Complainants
and OUII filed their opening written
submissions on remedy, the public
interest, and bonding. On November 12,
2021, OUII filed its responsive written
submission. No other submissions were
received by the Commission.
Having reviewed the submissions
filed in response to the Commission
request for briefing and the evidentiary
record, the Commission has determined
that the appropriate form of relief in this
investigation is a GEO prohibiting the
unlicensed importation of certain
vacuum insulated flasks and
components thereof that infringe the
sole claims of the D’468, D’012, and
D’320 patents and the ’784, ’365, and
’888 trademarks.
The Commission has further
determined that the public interest
factors enumerated in subsection (d)(1)
(19 U.S.C. 1337(d)(1)) do not preclude
issuance of the above-referenced
remedial order. Finally, the Commission
has determined that a bond in the
amount of one hundred (100) percent of
the entered value is required to permit
temporary importation of the articles in
question during the period of
Presidential review (19 U.S.C. 1337(j)).
The investigation is terminated.
The Commission’s order and the
record upon which it based its
determination were delivered to the
President and to the United States Trade
Representative on the day of their
issuance. The Commission has also
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
notified the Secretary of the Treasury of
the order.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended, 19 U.S.C. 1337, and in part
210 of the Commission’s Rules of
Practice and Procedure, 19 CFR part
210.
The Commission vote for this
determination took place on January 5,
2022.
By order of the Commission.
Issued: January 5, 2022.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2022–00281 Filed 1–10–22; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–939]
Bulk Manufacturer of Controlled
Substances Application: Curia
Missouri Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Curia Missouri Inc. has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 14, 2022. Such persons
may also file a written request for a
hearing on the application on or before
March 14, 2022.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUMMARY:
In
accordance with 21 CFR 1301.33(a), this
is notice that on August 19, 2021, Curia
Missouri Inc., 2460 West Bennett Street,
Springfield, Missouri 65807, applied to
be registered as a bulk manufacturer of
the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled
substance
Gamma Hydroxybutyric Acid.
E:\FR\FM\11JAN1.SGM
11JAN1
Drug code
2010
Schedule
I
1435
Federal Register / Vol. 87, No. 7 / Tuesday, January 11, 2022 / Notices
Controlled substance
Drug code
Amphetamine ...
Lisdexamphetamine.
Methylphenidate
Phenylacetone ..
Tapentadol ........
1100
1205
II
II
1724
8501
9780
II
II
II
The company plans to bulk
manufacture the above-listed controlled
substances in bulk for distribution to its
customers. No other activities for these
drug codes are authorized for this
registration.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2022–00325 Filed 1–10–22; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–942]
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey, Inc.
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice of application.
Johnson Matthey, Inc., has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 14, 2022. Such persons
may also file a written request for a
hearing on the application on or before
March 14, 2022.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
khammond on DSKJM1Z7X2PROD with NOTICES
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on November 2, 2021,
Johnson Matthey, Inc., 2003 Nolte Drive
West Deptford, New Jersey 08066–1742,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
20:22 Jan 10, 2022
Jkt 256001
Drug
Code
Controlled Substance
Schedule
Gamma Hydroxybutyric Acid ..
Marihuana ...............................
Tetrahydrocannabinols ...........
Noroxymorphone ....................
Difenoxin .................................
Amphetamine ..........................
Methamphetamine ..................
Lisdexamfetamine ...................
Methylphenidate ......................
Nabilone ..................................
4-Anilino-N-Phenethyl-4-Piperidine (ANPP).
Norfentanyl ..............................
Cocaine ...................................
Codeine ...................................
Dihydrocodeine .......................
Oxycodone ..............................
Hydromorphone ......................
Diphenoxylate .........................
Ecgonine .................................
Hydrocodone ...........................
Levorphanol ............................
Meperidine ..............................
Methadone ..............................
Methadone intermediate .........
Morphine .................................
Thebaine .................................
Opium tincture ........................
Oxymorphone .........................
Noroxymorphone ....................
Alfentanil .................................
Remifentanil ............................
Sufentanil ................................
Tapentadol ..............................
Fentanyl ..................................
Schedule
2010
7360
7370
9145
9168
1100
1105
1205
1724
7379
8333
I
I
I
I
I
II
II
II
II
II
II
8366
9041
9050
9120
9143
9150
9170
9180
9193
9220
9230
9250
9254
9300
9333
9630
9652
9668
9737
9739
9740
9780
9801
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to bulk
manufacture the listed controlled
substances for the internal use
intermediates or for sale to its
customers. In reference to drug codes
7360 (Marihuana), and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. The company plans to bulk
manufacture for either internal usage as
intermediates or to sale to customers as
Active Pharmaceutical Ingredients
(API). No other activities for these drug
codes are authorized for this
registration.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2022–00326 Filed 1–10–22; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–944]
Importer of Controlled Substances
Application: Nexus Pharmaceuticals,
Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before February 10, 2022. Such
persons may also file a written request
for a hearing on the application on or
before February 10, 2022.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on October 25, 2021,
Nexus Pharmaceuticals, Inc., 10300
128th Avenue, Pleasant Prairie,
Wisconsin 53158–7338, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Controlled
substance
Remifentanil ......
Drug code
9739
Schedule
I
The company plans to import the
listed controlled substance for research
and analytical testing purposes.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale. No other activity for
this drug code is authorized for this
registration.
Brian S. Besser,
Acting Assistant Administrator.
Nexus Pharmaceuticals, Inc.
has applied to be registered as an
SUMMARY:
importer of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
[FR Doc. 2022–00329 Filed 1–10–22; 8:45 am]
BILLING CODE P
E:\FR\FM\11JAN1.SGM
11JAN1
]]>Agencies
[Federal Register Volume 87, Number 7 (Tuesday, January 11, 2022)]
[Notices]
[Pages 1434-1435]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-00325]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-939]
Bulk Manufacturer of Controlled Substances Application: Curia
Missouri Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Curia Missouri Inc. has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before March 14, 2022.
Such persons may also file a written request for a hearing on the
application on or before March 14, 2022.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on August 19, 2021, Curia Missouri Inc., 2460 West
Bennett Street, Springfield, Missouri 65807, applied to be registered
as a bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.......... 2010 I
[[Page 1435]]
Amphetamine........................ 1100 II
Lisdexamphetamine.................. 1205 II
Methylphenidate.................... 1724 II
Phenylacetone...................... 8501 II
Tapentadol......................... 9780 II
------------------------------------------------------------------------
The company plans to bulk manufacture the above-listed controlled
substances in bulk for distribution to its customers. No other
activities for these drug codes are authorized for this registration.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2022-00325 Filed 1-10-22; 8:45 am]
BILLING CODE P
